Warner Chilcott Return on Equity
Warner Chilcott Historical Return on Equity Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| June 30, 2012 | 274.7% |
| March 31, 2012 | 633.2% |
| Dec. 31, 2011 | 9984% |
| Sept. 30, 2011 | |
| June 30, 2011 | 33.74% |
| March 31, 2011 | 22.61% |
| Dec. 31, 2010 | 15.31% |
| Sept. 30, 2010 | 9.68% |
| June 30, 2010 | 28.21% |
| March 31, 2010 | 26.65% |
| Dec. 31, 2009 | 32.17% |
About Return on Equity (ROE)
Return on equity (ROE) measures the rate of return on the money invested by common stock owners and retained by the company thanks to previous profitable years. It demonstrates a company's ability to generate profits from shareholders' equity (also known as net assets or assets minus liabilities).
ROE shows how well a company uses investment funds to generate growth. Return on equity is useful for comparing the profitability of companies within a sector or industry.
Investors generally are interested in company's that have high, increasing returns on equity.
Learn More
WCRX Return on Equity Benchmarks
| Companies | |
|---|---|
| Actavis | -1.64% |
| Mylan | 18.44% |
| Valeant Pharmaceuticals International | -3.46% |
WCRX Return on Equity Range, Past 5 Years
| Minimum | -0.60% | Dec 2008 |
| Maximum | 9984% | Dec 2011 |
| Average | 694.0% |
